Literature DB >> 15605002

An endoscopic study of upper-GI mucosal changes in patients with congestive heart failure.

Kaiser Raja1, Rakesh Kochhar, Pradeepta K Sethy, Usha Dutta, Harinder K Bali, Jagmohan S Varma.   

Abstract

BACKGROUND: Congestive heart failure results in an increase in systemic venous pressure that is transmitted to the inferior vena cava and to the hepatic veins. This can cause GI vascular and mucosal congestion. The aim of this study was to define upper-GI mucosal changes in patients with congestive heart failure.
METHODS: A total of 57 patients with congestive heart failure presenting with GI symptoms underwent upper endoscopy. Echocardiography was performed in all patients to determine the ejection fraction and the degree of tricuspid regurgitation. Transabdominal US was performed to measure the diameters of the hepatic veins, the inferior vena cava, and the portal vein. The presence and the severity of gastropathy and duodenopathy were compared with the parameters relating to severity of cardiac failure.
RESULTS: Of the 57 patients studied, gastric mucosal changes were observed in 50 (88%), duodenal mucosal changes in 31 (54%), and esophageal mucosal changes in none. Gastric mucosal changes were the following: mosaic-like pattern (n = 50), punctate spots (n = 34), thickened folds (n = 5), watermelon stomach (n = 3), and telangiectasia (n = 10). Duodenal mucosal changes were the following: mosaic-like pattern (n = 29), thickened folds (n = 8), and telangiectasia (n = 2). Upper-GI symptoms were associated with gastropathy ( p = 0.027) and duodenopathy ( p = 0.003). The presence and the severity of duodenopathy showed a high degree of positive correlation with the presence and the severity of gastropathy (gamma value 0.690; p value <0.001). Patients with gastropathy and duodenopathy had higher mean inferior vena cava and hepatic vein diameters than those without gastropathy and duodenopathy. The severity of duodenopathy but not that of gastropathy was significantly associated with increasing severity of tricuspid regurgitation ( p = 0.001), larger portal vein diameter ( p = 0.02), and lower ejection fraction ( p = 0.008).
CONCLUSIONS: Among patients with congestive cardiac failure with GI symptoms, changes of congestive gastropathy are evident in 88% and duodenopathy in 54%. The presence and the severity of duodenopathy was significantly associated with increasing severity of features of congestive heart failure.

Entities:  

Mesh:

Year:  2004        PMID: 15605002     DOI: 10.1016/s0016-5107(04)02222-9

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  8 in total

1.  Nodular gastritis in a patient with myopericarditis.

Authors:  Ming-Jen Chen; Wen-Hsiung Chang; Shou-Chuan Shih; Cheng-Hsin Chu; Tsang-En Wang; Shee-Chan Lin
Journal:  Dig Dis Sci       Date:  2007-04-04       Impact factor: 3.199

Review 2.  Iron and anemia in human biology: a review of mechanisms.

Authors:  Garry J Handelman; Nathan W Levin
Journal:  Heart Fail Rev       Date:  2008-03-25       Impact factor: 4.214

Review 3.  Mechanisms for cachexia in heart failure.

Authors:  Vincent Pureza; Viorel G Florea
Journal:  Curr Heart Fail Rep       Date:  2013-12

4.  Hyperplastic Polyposis following Treatment of Gastric Vascular Ectasia: A Case Report and Review of Clinical Correlates.

Authors:  M Ghabril; S Gross; M Krishna; M Raimondo
Journal:  Case Rep Gastroenterol       Date:  2007-08-07

Review 5.  Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology.

Authors:  Ridha I S Alnuwaysir; Martijn F Hoes; Dirk J van Veldhuisen; Peter van der Meer; Niels Grote Beverborg
Journal:  J Clin Med       Date:  2021-12-27       Impact factor: 4.964

6.  Fluctuating portal velocity tracing with rhythmicity: ultrasonic differential diagnosis and clinical significance.

Authors:  Qingxin Meng; Lei Lv; Bin Yang; Ninghua Fu; Guangming Lu
Journal:  Radiol Oncol       Date:  2012-04-19       Impact factor: 2.991

7.  Comparison of pancreatic and renal blood flow in a canine tachycardia-induced cardiomyopathy model.

Authors:  Aritada Yoshimura; Takahiro Ohmori; Shusaku Yamada; Takae Kawaguchi; Miori Kishimoto; Tomoko Iwanaga; Naoki Miura; Ryuji Fukushima
Journal:  J Vet Med Sci       Date:  2020-04-24       Impact factor: 1.267

8.  Cardiac Biomarkers and Subsequent Risk of Hospitalization With Bleeding in the Community: Atherosclerosis Risk in Communities Study.

Authors:  Lena Mathews; Junichi Ishigami; Ning Ding; Ron C Hoogeveen; Anna Kucharska-Newton; Christie M Ballantyne; Rebecca Gottesman; Elizabeth Selvin; Kunihiro Matsushita
Journal:  J Am Heart Assoc       Date:  2020-03-02       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.